HIGHLIGHTS
- who: Takahiro Kinami et al. from the Department of Gastroenterology, Graduate School of Biomedical and Health Sciences, Hiroshima University have published the Article: Evaluation of Response to Atezolizumab Plus Bevacizumab in Patients with Advanced Hepatocellular Carcinoma Using the Combination of Response Evaluation Criteria in Solid Tumors and Alpha-Fetoprotein, in the Journal: (JOURNAL)
- what: In the present study, the prognosis of SD and PD was not stratified at the first radiological response evaluation, so the cases that were SD at the second radiological response evaluation of efficacy were evaluated. The authors found no factors contributing . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.